Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Study Assessing SSR126517E Injections Once-weekly in Pulmonary Embolism Therapeutic Approach (CASSIOPEA)

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: June 27, 2006
Last updated: December 6, 2013
Last verified: December 2013